ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year

Following the joint statement from the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) on 11 July 2022, ECDC has released Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022. ECDC, in collaboration with the World Health Organization (WHO) Regional Office for Europe, has also published Operational considerations for respiratory virus surveillance in Europe.

Lesen Sie weiter auf: ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year
Quelle: European Centre for Disease Prevention and Control
Titelbild/Grafik by European Centre for Disease Prevention and Control

Kommentare und Fragen

Möchten Sie zu diesem Artikel ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!

Aktuelles von European Centre for Disease Prevention and Control

• Langya henipavirus under ECDC monitoring
• Weekly COVID-19 country overview
• Joint ECDC-WHO/Europe monkeypox surveillance bulletin
• Joint ECDC-WHO/Europe surveillance bulletin: Hepatitis of unknown origin in children
• World Hepatitis Day 2022
• Joint ECDC-WHO Europe COVID-19 surveillance bulletin
• ECDC to participate in a pilot project for the European Health Data Space: towards new opportunities for health research in Europe
• ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year
• 15 July update: Monophasic Salmonella Typhimurium outbreak linked to chocolate products
• ECDC Director statement on the Commission proposal for a new legislation on blood, tissues, and cells